In our paper, we used and recommended an iodometric (spectrophotometric) test to measure lipid peroxides in human plasma samples.' The use of a commercially available colour reagent (CHO-iodide; Merck, Germany) made the technique very simple and easy to use.
Not long after the paper had been published, we and others have had difficulties performing the test as it was described. Basically, the saline treated (control) sample resulted in higher absorbance than the colour reagent treated (test) sample. This was due to some as yet unidentified changes in the CHO-iodide reagent. The colour reagent presently available somehow quenches the original absorbance of plasma due to yellowish carotenoids. All our efforts to identify and eliminate this interference or change the protocol while measuring the formed I3 at 360 nm have failed.
We then adopted a technique, which measures iodine in the presence of starch as a blue colour iodine-starch complex at 560 nm,2 where the natural yellowish colour of plasma does not inferfere with the measurement. This modification has been in use for six months with different batches of CHOiodiode and produced reliable estimate of the overall oxidative capacity of plasma.
Reagents: CHOD-iodide (Merck, Germany). Butylated hydroxy toluene (BHT): 0 572 mg/ ml in ethanol. Starch (potato, soluble from Sigma, No. S-2630): A 1% solution is made freshly in 6-7 mM sodium chloride (39-2 mg/100 ml) by immersing into boiling water for a few minutes. After centrifugation (3 minutes at 12 000 rpm, Eppendorf centrifuge), the clear supernatant fluid is used the same day. Procedure: Blood is taken into EDTA (1-5 mg/ml), centrifuged, and the plasma samples kept at 4'C for no longer than two days. In a small phial, place 200 ul plasma, 1 0 ml colour reagent (CHOD), 10 Leonardi and colleagues,' is disappointing.
We have found a weak positive correlation between PCNA staining and Ki67 staining in both benign and malignant breast tumours (personal observation).
To some degree such observations may be related to the techniques used. Our practice with both Ki67 and PCNA is to count areas of highest antigen expression after scanning the slide at low magnification. This gives a measure of the maximum proliferative activity in any given tumour and obviates the need to decide how many areas of low and high concentration to include (not to mention the intermediate areas).
Using this method, we found no correlation between PCNA and mitotic count in carcinomas but a weak correlation (r = 043, p < 0 005) was obtained between Ki67 and PCNA in benign and malignant tumours.
As well as its extreme sensitivity to prolonged fixation and to heating on the slide before staining,2 another notable factor with PCNA we have observed is that prior freezing of tissue abolishes PCNA immunodetection, precluding the use of frozen tissue subsequently processed to paraffin wax such as obtains with biopsy specimens and small tumours.
These factors tend to reduce the efficacy of PCNA immunostaining, but the main problem with PCNA appears to be its overexpression. It is apparent when assessing PCNA expression that mitotic figures are frequently unstained. This is consistent with its described expression in the S-phase under optimal conditions.3Yet PCNA expression is frequently higher than Ki67 index' 2 as we have found, and higher than thymidine labelling in benign breast tissue. The interest of pathologists in interphase silver stained nucleolar organiser regions (AgNORs) has intensified since it was shown that malignant cells frequently have higher AgNOR numbers compared with corresponding benign or normal cells. Moreover, interphase AgNOR numbers are closely related to cell proliferative activity, suggesting that this parameter might also have prognostic importance.
Nucleolar organiser regions (NORs) are chromosomal segments which contain ribosomal genes. NORs are associated with a group of argyrophilic proteins, and can be visualised by silver staining in routinely processed cytological and histological samples. At light microscopic level AgNORs appear as well defined black dots, which in interphase cells are exclusively distributed throughout the lighter stained nucleoli. Each black dot corresponds, at the ultrastructural level, to a fibrillar centre with the surrounding dense fibrillar component. 
Method for grading breast cancer
Parham and colleagues' have proposed a new and "simplified" method for grading breast cancer and claim that it is superior to the Bloom and Richardson method,2 which they rightly criticise for its lack of precision. We agree entirely with this criticism, but are rather surprised that they do not refer to our recent publication in which, for precisely this reason, we have devised modifications which provide objective criteria for the evaluation of the three morphological components of histological grade.3 We have shown in a study of over 1500 patients that histological grade, using this method, provides powerful prognostic information, and in combination with tumour size and lymph node stage, forms the Nottingham Prognostic Index which can be used by clinicians to stratify patients for
